The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al
To better understand GHK-Cus mechanisms, well break down research behind the peptides potential applications for hair, skin, and other health aspects
Most data derives from individual peptide research, and human clinical trials for the combination are completely non-existent
It boosts fat oxidation, increases energy, and aids weight loss
NOTE: Because Copper Peptides thrive at a neutral pH (5.86.0) , they should not be applied at the exact same moment as acidic ingredients like Glycolic acid, Vitamin C (L-Ascorbic Acid) etc
